Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Houston, TX
SEC filing record 1 source field available
Fiscal year end
31 December
CNS Pharmaceuticals, Inc. has filed 379 SEC EDGAR filings since 13 Mar 2018

SEC filing history

Showing 1-13 of 13 matching filings.

Per page
25
Current page
1
10-K/A File 001-39126

AMENDMENT #1 TO FORM 10-K

Filing date
30 Apr 2026
Reporting date
31 Dec 2025
Next action
Verify source filing
10-K File 001-39126

FORM 10-K FOR DEC 2025

Filing date
31 Mar 2026
Reporting date
31 Dec 2025
Next action
Verify source filing
10-K/A File 001-39126

AMENDMENT NO. 1 TO FORM 10-K

Filing date
30 Apr 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
10-K File 001-39126

FORM 10-K FOR DEC 2024

Filing date
31 Mar 2025
Reporting date
31 Dec 2024
Next action
Verify source filing
10-K File 001-39126

FORM 10-K FOR 12-31-23

Filing date
01 Apr 2024
Reporting date
31 Dec 2023
Next action
Verify source filing
10-K/A File 001-39126

10-K/A

Filing date
01 May 2023
Reporting date
31 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-39126

FORM 10-K AMENDMENT 1

Filing date
29 Apr 2022
Reporting date
31 Dec 2021
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-39126

AMENDMENT #2 TO THE ANNUAL REPORT

Filing date
30 Apr 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-39126

AMENDED ANNUAL REPORT

Filing date
16 Feb 2021
Reporting date
31 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .